Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

New research suggests that a specific purple root vegetable could be the secret to naturally managing hypertension by ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving ...

Intervention/Treatment: The trial tested povorcitinib, an oral tablet, versus a matching placebo. Povorcitinib is designed to reduce inflammation that drives HS flare-ups and lesions. Participants ...

MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis: Ghent, Belgium Saturday, January 10, 2026, 16:00 Hrs [IST] MRM ...

Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...

Partnership expands access to clinically proven esophageal protection for atrial fibrillation ablation across federal ...

Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...

Think Academy concluded its participation at CES 2026 after generating strong interest around Class+, its AI-powered Intelligent Learning System, and a broader portfolio of education technology ...